SCHEMBL746622

SCHEMBL746622

CCc1ccc(N2CCC3(CCN(S(=O)(=O)c4ccccc4Cl)CC3)C2)cn1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 1/20 0.44
CHRM4 P08173 3/20 0.43
CYP3A4 P08684 8/20 0.42
CYP1A2 P05177 7/20 0.42
CYP2C9 P11712 6/20 0.42
ALDH1A1 P00352 6/20 0.42
CYP2D6 P10635 6/20 0.42
CYP2C19 P33261 6/20 0.42
TSHR P16473 4/20 0.42
SMN1; SMN2 Q16637 3/20 0.41
HSD17B10 Q99714 3/20 0.41
HPGD P15428 1/20 0.41
USP2 O75604 3/20 0.40
MAPK1 P28482 2/20 0.40
LIPE Q05469 2/20 0.40
KDM2B Q8NHM5 1/20 0.39
HIF1A Q16665 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL746711 0.85 CYP2C9 (0.48) CCR1CHRM4CYP3A4CYP1A2CYP2C9
SCHEMBL3744359 0.81 LIPE (0.58) CCR1CHRM4LIPE
SCHEMBL745542 0.79 CYP2C9 (0.52) CCR1CHRM4CYP3A4CYP1A2CYP2C9
SCHEMBL746534 0.76 CYP3A4 (0.48) CCR1CHRM4CYP3A4CYP1A2CYP2C9
SCHEMBL745067 0.76 CCR1 (0.39) CCR1CHRM4CYP3A4CYP1A2CYP2C9
SCHEMBL744218 0.74 CYP3A4 (0.52) CCR1CHRM4CYP3A4CYP1A2CYP2C9
SCHEMBL744430 0.74 LIPE (0.68) CCR1CYP3A4CYP1A2CYP2C9ALDH1A1
SCHEMBL744705 0.72 CYP1A2 (0.47) CCR1CHRM4CYP3A4CYP1A2CYP2C9
SCHEMBL744989 0.72 CYP3A4 (0.57) CCR1CHRM4CYP3A4CYP1A2CYP2C9
SCHEMBL745718 0.70 CYP2C9 (0.46) CYP3A4CYP1A2CYP2C9ALDH1A1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2430023-A1 AZACYCLIC SPIRODERIVATIVES AS HSL INHIBITORS F. Hoffmann-La Roche AG (CH) 2012-03-21 EP claimed
WO-2010130665-A1 AZACYCLIC SPIRODERIVATIVES AS HSL INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2010-11-18 WO claimed